Mérieux to sell stake in Swixx Biopharma to SK Capital

The transaction with SK Capital values the company in excess of €1.5 billion.

15 December 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Europe UK Western Europe Healthcare Briefs